Global Cell Therapy Manufacturing Market, By Therapy (T-Cell Therapies, Dendritic Cell Therapies, Tumor Cell Therapies, Stem Cell Therapies), By Source of Cell, By Scale of Operation, By Source, By Application, By End User, By Region, Competition Forecast and Opportunities, 2026

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Cell Therapy Manufacturing Market

5. Voice of Customers
5.1. Brand Awareness
5.2. Commonly Used Cell Therapies
5.3. Preferences Based on Source of Cell Among Medical Professionals

6. Global Cell Therapy Manufacturing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Therapy (T-Cell Therapies, Dendritic Cell Therapies, Tumor Cell Therapies, Stem Cell Therapies)
6.2.2. By Source of Cell (Autologous v/s Allogenic)
6.2.3. By Scale of Operation (Preclinical, Clinical, Commercial)
6.2.4. By Source (In-House v/s Contract Manufacturing)
6.2.5. By Application (Oncology, Cardiovascular Diseases, Orthopedic Diseases, Others)
6.2.6. By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)
6.2.7. By Company (2020)
6.2.8. By Region
6.3. Product Market Map
6.3.1. By Therapy
6.3.2. By Scale of Operation
6.3.3. By Source
6.3.4. By Application
6.3.5. By Region

7. North America Cell Therapy Manufacturing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Therapy
7.2.2. By Source of Cell
7.2.3. By Scale of Operation
7.2.4. By Source
7.2.5. By Application
7.2.6. By End User
7.2.7. By Country
7.3. North America: Country Analysis
7.3.1. United States Cell Therapy Manufacturing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Therapy
7.3.1.2.2. By Source of Cell
7.3.1.2.3. By Scale of Operation
7.3.1.2.4. By Source
7.3.1.2.5. By Application
7.3.1.2.6. By End User
7.3.2. Canada Cell Therapy Manufacturing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Therapy
7.3.2.2.2. By Source of Cell
7.3.2.2.3. By Scale of Operation
7.3.2.2.4. By Source
7.3.2.2.5. By Application
7.3.2.2.6. By End User
7.3.3. Mexico Cell Therapy Manufacturing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Therapy
7.3.3.2.2. By Source of Cell
7.3.3.2.3. By Scale of Operation
7.3.3.2.4. By Source
7.3.3.2.5. By Application
7.3.3.2.6. By End User

8. Europe Cell Therapy Manufacturing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Therapy
8.2.2. By Source of Cell
8.2.3. By Scale of Operation
8.2.4. By Source
8.2.5. By Application
8.2.6. By End User
8.2.7. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Cell Therapy Manufacturing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Therapy
8.3.1.2.2. By Source of Cell
8.3.1.2.3. By Scale of Operation
8.3.1.2.4. By Source
8.3.1.2.5. By Application
8.3.1.2.6. By End User
8.3.2. France Cell Therapy Manufacturing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Therapy
8.3.2.2.2. By Source of Cell
8.3.2.2.3. By Scale of Operation
8.3.2.2.4. By Source
8.3.2.2.5. By Application
8.3.2.2.6. By End User
8.3.3. United Kingdom Cell Therapy Manufacturing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Therapy
8.3.3.2.2. By Source of Cell
8.3.3.2.3. By Scale of Operation
8.3.3.2.4. By Source
8.3.3.2.5. By Application
8.3.3.2.6. By End User
8.3.4. Spain Cell Therapy Manufacturing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Therapy
8.3.4.2.2. By Source of Cell
8.3.4.2.3. By Scale of Operation
8.3.4.2.4. By Source
8.3.4.2.5. By Application
8.3.4.2.6. By End User
8.3.5. Italy Cell Therapy Manufacturing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Therapy
8.3.5.2.2. By Source of Cell
8.3.5.2.3. By Scale of Operation
8.3.5.2.4. By Source
8.3.5.2.5. By Application
8.3.5.2.6. By End User

9. Asia-Pacific Cell Therapy Manufacturing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Therapy
9.2.2. By Source of Cell
9.2.3. By Scale of Operation
9.2.4. By Source
9.2.5. By Application
9.2.6. By End User
9.2.7. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Cell Therapy Manufacturing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Therapy
9.3.1.2.2. By Source of Cell
9.3.1.2.3. By Scale of Operation
9.3.1.2.4. By Source
9.3.1.2.5. By Application
9.3.1.2.6. By End User
9.3.2. Japan Cell Therapy Manufacturing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Therapy
9.3.2.2.2. By Source of Cell
9.3.2.2.3. By Scale of Operation
9.3.2.2.4. By Source
9.3.2.2.5. By Application
9.3.2.2.6. By End User
9.3.3. South Korea Cell Therapy Manufacturing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Therapy
9.3.3.2.2. By Source of Cell
9.3.3.2.3. By Scale of Operation
9.3.3.2.4. By Source
9.3.3.2.5. By Application
9.3.3.2.6. By End User
9.3.4. Australia Cell Therapy Manufacturing Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Therapy
9.3.4.2.2. By Source of Cell
9.3.4.2.3. By Scale of Operation
9.3.4.2.4. By Source
9.3.4.2.5. By Application
9.3.4.2.6. By End User
9.3.5. India Cell Therapy Manufacturing Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Therapy
9.3.5.2.2. By Source of Cell
9.3.5.2.3. By Scale of Operation
9.3.5.2.4. By Source
9.3.5.2.5. By Application
9.3.5.2.6. By End User

10. South America Cell Therapy Manufacturing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Therapy
10.2.2. By Source of Cell
10.2.3. By Scale of Operation
10.2.4. By Source
10.2.5. By Application
10.2.6. By End User
10.2.7. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Cell Therapy Manufacturing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Therapy
10.3.1.2.2. By Source of Cell
10.3.1.2.3. By Scale of Operation
10.3.1.2.4. By Source
10.3.1.2.5. By Application
10.3.1.2.6. By End User
10.3.2. Argentina Cell Therapy Manufacturing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Therapy
10.3.2.2.2. By Source of Cell
10.3.2.2.3. By Scale of Operation
10.3.2.2.4. By Source
10.3.2.2.5. By Application
10.3.2.2.6. By End User
10.3.3. Colombia Cell Therapy Manufacturing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Therapy
10.3.3.2.2. By Source of Cell
10.3.3.2.3. By Scale of Operation
10.3.3.2.4. By Source
10.3.3.2.5. By Application
10.3.3.2.6. By End User

11. Middle East and Africa Cell Therapy Manufacturing Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Therapy
11.2.2. By Source of Cell
11.2.3. By Scale of Operation
11.2.4. By Source
11.2.5. By Application
11.2.6. By End User
11.2.7. By Country
11.3. MEA: Country Analysis
11.3.1. Israel Cell Therapy Manufacturing Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Therapy
11.3.1.2.2. By Source of Cell
11.3.1.2.3. By Scale of Operation
11.3.1.2.4. By Source
11.3.1.2.5. By Application
11.3.1.2.6. By End User
11.3.2. South Africa Cell Therapy Manufacturing Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Therapy
11.3.2.2.2. By Source of Cell
11.3.2.2.3. By Scale of Operation
11.3.2.2.4. By Source
11.3.2.2.5. By Application
11.3.2.2.6. By End User
11.3.3. Saudi Arabia Cell Therapy Manufacturing Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Therapy
11.3.3.2.2. By Source of Cell
11.3.3.2.3. By Scale of Operation
11.3.3.2.4. By Source
11.3.3.2.5. By Application
11.3.3.2.6. By End User
11.3.4. UAE Cell Therapy Manufacturing Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Therapy
11.3.4.2.2. By Source of Cell
11.3.4.2.3. By Scale of Operation
11.3.4.2.4. By Source
11.3.4.2.5. By Application
11.3.4.2.6. By End User

12. Market Dynamics
12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Clinical Trials

15. Patent Analysis

16. Competitive Landscape
16.1. Competition Outlook
16.2. Company Profiles (SWOT Analysis of Top 5 Players Profiled)
16.2.1. Novartis AG
16.2.2. F. Hoffmann La Roche AG
16.2.3. Gilead Sciences, Inc.
16.2.4. Thermo Fischer Scientific, Inc.
16.2.5. Catalent, Inc.
16.2.6. JSR Life Sciences LLC (KBI Biopharma Inc)
16.2.7. Waisman Center (Waisman Biomanufacturing)
16.2.8. Cell and Gene Therapy Catapult
16.2.9. Merck KGaA
16.2.10. Lonza Group
16.2.11. Oxford Biomedica Plc
16.2.12. WuXi AppTec
16.2.13. Charles River Laboratories International Inc.
16.2.14. Institut Merieux (ABL Inc.)
16.2.15. BioCentriq
16.2.16. Centre for Commercialization of Regenerative Medicine (CCRM)
16.2.17. Fujifilm Holdings Corporation (Fujifilm Cellular Dynamics)
16.2.18. Amgen Inc.
16.2.19. Bluebird Bio Inc.
16.2.20. Takeda Pharmaceutical Company Limited

17. Strategic RecommendationsList of FiguresFigure 1: Global Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 2: Global Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 3: Global Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 4: Global Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 5: Global Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 6: Global Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 7: Global Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 8: Global Cell Therapy Manufacturing Market Share, By Region, By Value, 2016-2026F
Figure 9: Global Cell Therapy Manufacturing Market Share, By Company, By Value, 2020
Figure 10: Global Cell Therapy Manufacturing Market Map, By Therapy, Market Size (USD Million) & Growth Rate (%), 2020
Figure 11: Global Cell Therapy Manufacturing Market Map, By Scale of Operations, Market Size (USD Million) & Growth Rate (%), 2020
Figure 12: Global Cell Therapy Manufacturing Market Map, By Source, Market Size (USD Million) & Growth Rate (%), 2020
Figure 13: Global Cell Therapy Manufacturing Market Map, By Application, Market Size (USD Million) & Growth Rate (%), 2020
Figure 14: Global Cell Therapy Manufacturing Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2020
Figure 15: North America Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 16: North America Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 17: North America Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 18: North America Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 19: North America Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 20: North America Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 21: North America Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 22: North America Cell Therapy Manufacturing Market Share, By Country, By Value, 2016-2026F
Figure 23: United States Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 24: United States Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 25: United States Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 26: United States Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 27: United States Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 28: United States Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 29: United States Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 30: Canada Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 31: Canada Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 32: Canada Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 33: Canada Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 34: Canada Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 35: Canada Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 36: Canada Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 37: Mexico Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 38: Mexico Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 39: Mexico Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 40: Mexico Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 41: Mexico Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 42: Mexico Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 43: Mexico Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 44: Europe Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 45: Europe Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 46: Europe Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 47: Europe Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 48: Europe Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 49: Europe Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 50: Europe Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 51: Europe Cell Therapy Manufacturing Market Share, By Country, By Value, 2016-2026F
Figure 52: Germany Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 53: Germany Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 54: Germany Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 55: Germany Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 56: Germany Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 57: Germany Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 58: Germany Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 59: France Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 60: France Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 61: France Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 62: France Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 63: France Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 64: France Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 65: France Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 66: United Kingdom Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 67: United Kingdom Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 68: United Kingdom Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 69: United Kingdom Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 70: United Kingdom Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 71: United Kingdom Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 72: United Kingdom Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 73: Spain Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 74: Spain Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 75: Spain Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 76: Spain Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 77: Spain Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 78: Spain Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 79: Spain Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 80: Italy Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 81: Italy Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 82: Italy Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 83: Italy Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 84: Italy Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 85: Italy Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 86: Italy Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 87: Asia Pacific Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 88: Asia Pacific Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 89: Asia Pacific Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 90: Asia Pacific Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 91: Asia Pacific Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 92: Asia Pacific Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 93: Asia Pacific Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 94: Asia Pacific Cell Therapy Manufacturing Market Share, By Country, By Value, 2016-2026F
Figure 95: China Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 96: China Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 97: China Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 98: China Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 99: China Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 100: China Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 101: China Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 102: Japan Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 103: Japan Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 104: Japan Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 105: Japan Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 106: Japan Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 107: Japan Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 108: Japan Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 109: South Korea Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 110: South Korea Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 111: South Korea Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 112: South Korea Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 113: South Korea Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 114: South Korea Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 115: South Korea Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 116: Australia Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 117: Australia Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 118: Australia Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 119: Australia Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 120: Australia Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 121: Australia Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 122: Australia Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 123: India Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 124: India Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 125: India Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 126: India Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 127: India Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 128: India Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 129: India Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 130: South America Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 131: South America Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 132: South America Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 133: South America Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 134: South America Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 135: South America Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 136: South America Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 137: South America Cell Therapy Manufacturing Market Share, By Country, By Value, 2016-2026F
Figure 138: Brazil Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 139: Brazil Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 140: Brazil Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 141: Brazil Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 142: Brazil Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 143: Brazil Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 144: Brazil Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 145: Argentina Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 146: Argentina Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 147: Argentina Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 148: Argentina Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 149: Argentina Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 150: Argentina Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 151: Argentina Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 152: Colombia Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 153: Colombia Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 154: Colombia Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 155: Colombia Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 156: Colombia Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 157: Colombia Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 158: Colombia Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 159: Middle East & Africa Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 160: Middle East & Africa Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 161: Middle East & Africa Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 162: Middle East & Africa Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 163: Middle East & Africa Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 164: Middle East & Africa Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 165: Middle East & Africa Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 166: Middle East & Africa Cell Therapy Manufacturing Market Share, By Country, By Value, 2016-2026F
Figure 167: Israel Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 168: Israel Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 169: Israel Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 170: Israel Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 171: Israel Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 172: Israel Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 173: Israel Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 174: South Africa Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 175: South Africa Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 176: South Africa Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 177: South Africa Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 178: South Africa Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 179: South Africa Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 180: South Africa Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 181: Saudi Arabia Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 182: Saudi Arabia Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 183: Saudi Arabia Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 184: Saudi Arabia Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 185: Saudi Arabia Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 186: Saudi Arabia Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 187: Saudi Arabia Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 188: UAE Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 189: UAE Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 190: UAE Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 191: UAE Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 192: UAE Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 193: UAE Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 194: UAE Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 195: Clinical Trials Studies on Cell Therapy Manufacturing from 2016 & 2020
Figure 196: Number of Cell Therapy Manufacturing Patents Application and Granted Patents from 2016-2021
Figure 197: Number of Cell Therapy Manufacturing Patents Filled, Granted, Published from 2016-2021 (November)
Figure 198: Cell Therapy Manufacturing Patents Legal Status from 2020-2021 (November)
Figure 199: Percentage of Patents Applicants vs Owners in 2021List of TablesTable 1: Number of Persons Aged 65 Years or Above by Geographic Region, 2019 and 2050
Table 2: Clinically Approved Cell Therapies
Table 3: Clinical Trial Studies on Cell Therapy Manufacturing till November 2021
Table 4: List of Some Recent Patents in Cell Therapy Manufacturing

• Novartis AG
• F. Hoffmann La Roche AG
• Gilead Sciences, Inc.
• Thermo Fischer Scientific, Inc.
• Catalent, Inc.
• JSR Life Sciences LLC (KBI Biopharma Inc)
• Waisman Center (Waisman Biomanufacturing)
• Cell and Gene Therapy Catapult
• Merck KGaA
• Lonza Group
• Oxford Biomedica Plc
• WuXi AppTec
• Charles River Laboratories International Inc.
• Institut Merieux (ABL Inc.)
• BioCentriq
• Centre for Commercialization of Regenerative Medicine (CCRM)
• Fujifilm Holdings Corporation (Fujifilm Cellular Dynamics)
• Amgen Inc.
• Bluebird Bio Inc.
• Takeda Pharmaceutical Company Limited